Related Experiment Videos
Schedule as a determinant of cytotoxic drug activity
1Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Current Opinion in Oncology
|December 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.
NPJ precision oncology·2022
Long term outcome and elasticity of a polyester mesh used for laparoscopic ventral hernia repair.
Hernia : the journal of hernias and abdominal wall surgery·2021
Subcutaneous and visceral adipose tissue in patients with primary and recurrent incisional hernia.
Hernia : the journal of hernias and abdominal wall surgery·2021
Radiology teaching improves Anatomy scores for medical students.
The British journal of radiology·2020
Undergraduate medical education: a national survey of consultant radiologists.
The British journal of radiology·2020
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Antibody-drug conjugates in breast cancer: the first-line and curative setting.
Current opinion in oncology·2026
Haemophagocytic lymphohistiocytosis: a life threatening complication of lymphoma.
Current opinion in oncology·2026
Artificial intelligence for systemic therapy selection and prediction of outcomes in advanced gynecological cancers.
Current opinion in oncology·2026
Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.
Current opinion in oncology·2026